Watchlist Price Alert

Rapport Therapeutics Inc.... (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

10.97

-0.23 (-2.05%)

At close: Jun 17, 2025, 12:44 PM

-2.05% (1D)

Bid	10.89
Market Cap	400.38M
Revenue (ttm)	n/a
Net Income (ttm)	-79.7M
EPS (ttm)	-3.82
PE Ratio (ttm)	-2.87
Forward PE	-2.59
Analyst	Buy

Ask	11.02
Volume	39,015
Avg. Volume (20D)	210,242
Open	11.39
Previous Close	11.20
Day's Range	10.85 - 11.37
52-Week Range	6.43 - 29.74
Beta	-0.88

About RAPP

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RAPP

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RAPP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 weeks ago

+13.66%

Rapport Therapeutics shares are trading higher aft... Unlock content with Pro Subscription

News

5 days ago · marketbeat.com

Analysts Can't Get Enough of These Little-Known Biopharma Stocks

The biopharmaceuticals industry is both exciting and risky for investors. Many leading growth stocks in the U.S. market are found in this sector, due to the significant rallies that biopharmaceutical ...

1 month ago · nytimes.com

Meloni and Trump: An Oval Office Meeting With Rapport and Banter

In their meeting, President Trump made clear that he had special regard for Prime Minister Giorgia Meloni of Italy. She said he had accepted an invitation to go to Rome.